raloxifene hydrochloride has been researched along with Polyps in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cecchini, RS; Costantino, JP; Cronin, WM; Ford, LG; Runowicz, CD; Vogel, VG; Wickerham, DL; Wolmark, N | 1 |
Goksedef, BP; Kutuk, MS | 1 |
Alam, J; Bhattoa, HP; Cox, DA; Dowsett, SA; Goldstein, SR; Muram, D; Neven, P; Sipos, A | 1 |
Bontis, J; Dinas, K; Tsalikis, T; Zafrakas, M; Zepiridis, L | 1 |
Avila, N; Eng-Wong, J; Forman, MR; Johnson, DV; Premkumar, A; Remaley, AT; Stratton, P; Venzon, DJ; Zujewski, J | 1 |
Cianci, A; Cicinelli, E; De Leo, V; Pinto, V; Saliani, N; Tinelli, R | 1 |
3 trial(s) available for raloxifene hydrochloride and Polyps
Article | Year |
---|---|
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; Female; Genital Diseases, Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Uterine Hemorrhage; Vaginitis; Vulvitis | 2012 |
Gynecologic and hormonal effects of raloxifene in premenopausal women.
Topics: Adult; Breast Neoplasms; Calcium Carbonate; Carcinoma; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Female; Genitalia, Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Middle Aged; Polyps; Premenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Diseases | 2007 |
Rapid endometrial preparation for hysteroscopic surgery with oral desogestrel plus vaginal raloxifene: a prospective, randomized pilot study.
Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Endometrium; Estrogen Antagonists; Female; Humans; Hysteroscopy; Menstrual Cycle; Pilot Projects; Polyps; Premenopause; Raloxifene Hydrochloride; Treatment Outcome; Uterine Diseases | 2007 |
3 other study(ies) available for raloxifene hydrochloride and Polyps
Article | Year |
---|---|
Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Estrogen Antagonists; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Leiomyoma; Middle Aged; Ovarian Cysts; Polyps; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms; Vaginal Discharge | 2011 |
A postmenopausal woman developed a giant endometrial polyp during Raloxifene treatment.
Topics: Bone Density Conservation Agents; Female; Humans; Middle Aged; Polyps; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Uterine Diseases | 2011 |
Endometrial lesions causing uterine bleeding in postmenopausal women receiving raloxifene.
Topics: Administration, Oral; Adult; Endometrial Hyperplasia; Endometrium; Female; Humans; Osteoporosis, Postmenopausal; Polyps; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Uterine Diseases; Uterine Hemorrhage | 2005 |